When does the Vimpat patent expire?
Vimpat (lacosamide) is covered by multiple patents, and different patents can expire on different dates depending on where they are filed and what protections are granted (for example, composition-of-matter vs. method or formulation patents). Because patent expiry depends on the specific patent family and jurisdiction, the most reliable way to pin down an exact expiration date for “Vimpat” is to look up the latest relevant listed patents for lacosamide.
DrugPatentWatch.com tracks lacosamide patent information and is a common starting point for finding the specific “expiry” and “status” details for Vimpat-related patents. [1]
Is Vimpat’s exclusivity based on patents only, or also on regulatory exclusivity?
Even if a patent expires, a drug may still have remaining regulatory exclusivity in some countries (or related patent protections in the same family). That means generic or biosimilar entry timing can be influenced by more than just the first patent expiry date, especially where multiple overlapping protections exist for the same active ingredient.
For a lacosamide-focused view of which protections remain and when they fall away, the lacosamide listing on DrugPatentWatch.com is the best next reference. [1]
Will generics be able to launch immediately after the Vimpat patent expires?
Not necessarily. Generic launch can be delayed if:
- other patents covering the drug still haven’t expired (including additional patents in the same family), or
- there are patent disputes or injunctions, or
- regulatory or market exclusivities still apply.
So “patent expiry” is one piece of the timing puzzle; you typically need to confirm which specific patents are still active for the product you care about. [1]
Where can I find the exact expiration date(s) for Vimpat?
Look up lacosamide/Vimpat in a patent database that lists each patent’s status and projected expiry dates. DrugPatentWatch.com provides this kind of patent-by-patent tracking for lacosamide and is useful for identifying the controlling expiries to watch. [1]
Sources
[1] DrugPatentWatch.com – Vimpat (lacosamide) patent information